Search results for “Cftr gene” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 186 patents, we discovered top 43 key players by total patent application. Quest Diagnostics Investments LLC, BioArray Solutions Ltd., Yissum Research Development Co. Ltd. are dominant in this area. They take 28.49% of the total patent filing.
Quest Diagnostics Investments LLC
New Jersey, United States
Patent: 20
BioArray Solutions Ltd.
New Jersey, United States
Patent: 18
Yissum Research Development Co. Ltd.
Israel
Patent: 15
AlgiPharma AS
Akershus, Norway
Patent: 12
Sangamo Therapeutics, Inc.
California, United States
Patent: 11
Third Wave Technologies, Inc.
Wisconsin, United States
Patent: 8
STARTUP
SpliSense Ltd.
Israel
Patent: 8
ProQR Therapeutics II BV
Zuid-Holland, Netherlands
Patent: 7
F. Hoffmann-La Roche Ltd.
Switzerland
Patent: 6
IP2IPO Innovations Ltd.
United Kingdom
Patent: 6
Startups & Unicorns
Order by:
Innovation Intensity
With the analysis among 17 patents, we discovered top 2 start-ups by total patent application.
STARTUP
Institut National de la Santé et de la Recherche Médicale
France
Patent: 9
STARTUP
SpliSense Ltd.
Israel
Patent: 8
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 39 patents applied in the last 5 years. We discover 18 most active companies in this area. The fast-growing Yissum Research Development Co. Ltd., SpliSense Ltd., enGene, Inc. take 53.85% of patent filing during this period.
Yissum Research Development Co. Ltd.
Israel
Patent: 10
STARTUP
SpliSense Ltd.
Israel
Patent: 8
enGene, Inc.
British Columbia, Canada
Patent: 3
Sangamo Therapeutics, Inc.
California, United States
Patent: 3
University of Pretoria
South Africa
Patent: 2
Istituto Giannina Gaslini
Liguria, Italy
Patent: 2
Universita' Degli Studi di Roma La Sapienza
Italy
Patent: 2
Quest Diagnostics Investments LLC
New Jersey, United States
Patent: 2
Italian Cystic Fibrosis Research Foundation
VERONA, Italy
Patent: 2
Shenzhen People's Hospital
Guangdong Sheng, China
Patent: 1
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 39 patents in last 5 years, we discover 11 new entrants. SpliSense Ltd., enGene, Inc., Universita' Degli Studi di Roma La Sapienza are the most active new entrants in this area.
STARTUP
SpliSense Ltd.
Israel
Patent: 8
enGene, Inc.
British Columbia, Canada
Patent: 3
Universita' Degli Studi di Roma La Sapienza
Italy
Patent: 2
Istituto Giannina Gaslini
Liguria, Italy
Patent: 2
Italian Cystic Fibrosis Research Foundation
VERONA, Italy
Patent: 2
Shenzhen People's Hospital
Guangdong Sheng, China
Patent: 1
Sun Pharmaceutical Industries Ltd.
Maharashtra, India
Patent: 1
CHIESI Farmaceutici SpA
Emilia-Romagna, Italy
Patent: 1
UCB Biopharma SRL
Belgium
Patent: 1
Nanjing Qizhen Genetic Engineering Co., Ltd.
Jiangsu Sheng, China
Patent: 1
Research Institutions
Order by:
Innovation Intensity
With the analysis among 60 patents, we discovered top 7 universities and scientific research institutions by total patent application. University of Pretoria, Yale University, The Johns Hopkins University are dominant in this area. They take 43.33% of the total patent filing.
University of Pretoria
South Africa
Patent: 7
Yale University
Connecticut, United States
Patent: 3
The Johns Hopkins University
United States
Patent: 2
Sun Yat-Sen University
Guangdong Sheng, China
Patent: 1
The University of Western Australia
Tasmania, Australia
Patent: 1
Yonsei University
South Korea
Patent: 1
Foshan University
Guangdong Sheng, China
Patent: 1
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: